Letter to the Editor: Temporal dynamics of anxiety and depression from pregnancy to postpartum: Insights, limitations, and clinical implications

Abstract

We read with great interest the study by Gao and Lu published in the World Journal of Psychiatry. Anxiety and depressive symptoms during pregnancy are important predictors of postpartum depression, yet their temporal dynamics remain incompletely understood. The authors use a cross-lagged time series model to examine how anxiety and depression at different gestational stages influence postpartum outcomes. This provides insight into fluctuations in maternal mental health and highlights critical windows for early identification and intervention. However, the retrospective design limits understanding of underlying stressors, as no patient-reported questionnaires were used. Population-specific characteristics, reliance on hospital records, and differing screening instruments may reduce generalizability and affect observed associations. Future research should develop prospective, standardized tools to assess maternal mental health, investigate biological, psychosocial, and environmental contributors, and examine patterns of mild-to-moderate symptom fluctuations. Overall, this work advances understanding of maternal mental health trajectories and supports a proactive, stage-specific approach to early detection and intervention, ultimately aiming to reduce the global burden of postpartum depression.

Key Words: Pregnancy-related anxiety; Depressive symptoms; Postpartum depression; Maternal mental health; Cross-lagged time series analysis; Gestational stages

Core Tip: This letter highlights the value of modeling anxiety and depressive symptoms across pregnancy to better understand their evolving influence on postpartum depression. By emphasizing time-dependent interactions rather than static measurements, the discussed study identifies critical gestational windows for early risk detection. The findings support a shift toward stage-specific screening strategies and proactive intervention during pregnancy. Future research integrating prospective designs and standardized assessments may further refine prevention efforts and reduce the global burden of postpartum depression.

TO THE EDITOR

Perinatal mental health is a cornerstone of public health, with maternal depression and anxiety exerting profound effects on both the mother and child’s long-term wellbeing[1]. While postpartum depression (PPD) is a well-defined clinical endpoint, the emotional continuum that precedes it, spanning the entire pregnancy, often receives fragmented clinical and research attention. The original article published in the World Journal of Psychiatry by Gao and Lu[2] is a retrospective study that included 572 women assessed at four timepoints: Early (1-13 weeks), mid (14-27 weeks), late pregnancy (≥ 28 weeks), and six weeks postpartum. Anxiety and depressive symptoms were measured using the generalized anxiety disorder-7 and the patient health questionnaire-9 (PHQ-9) during pregnancy, and the Edinburgh Postnatal Depression Scale (EPDS) postpartum. Their work compellingly demonstrates that to effectively prevent PPD, we must first understand the predictive pathway that begins in early pregnancy.

From association to prediction: The value of temporal modeling

The primary contribution of this study lies in its application of time-series analysis. By modeling data from early, mid, and late pregnancy through to six weeks postpartum, the statistical analysis showed significant fluctuations in anxiety (χ² = 21.092, P < 0.001) and depression (χ² = 13.619, P < 0.001) across pregnancy stages. The cross-lagged model confirmed significant time-lagged effects of prenatal symptoms on postpartum outcomes (P < 0.001) and demonstrated good fit (χ²/df = 2.761; root mean square error of approximation = 0.012; comparative fit index = 0.965; normed fit index = 0.975). The Tucker-Lewis index was not reported, but the reported indices suggest strong model performance[2]. This finding is more than a correlation; it suggests a directional relationship where prenatal distress acts as a potential prodrome or risk factor. The identified trajectory, a peak in symptoms during mid-pregnancy, a decline in the third trimester, and a rebound postpartum, offers a clinically actionable map. It strongly implicates the second trimester, a period often dominated by fetal anomaly screenings, significant bodily changes[3], maternal identity transitions and increased anxiety related to pregnancy outcomes[4], as a critical window of vulnerability. This insight is invaluable for timing interventions, suggesting that resources for screening and support should be intensified during this specific gestational phase.

Clinical imperatives: Shifting from reactive to proactive care

These findings provide robust empirical support for a paradigm shift in perinatal care. The traditional model, which often initiates mental health screening after delivery, is reactive and misses the opportunity for primary prevention[5]. Gao and Lu’s work[2] is a clarion call for the mandatory integration of serial, standardized mental health assessments into routine prenatal visits. We acknowledge that implementing mandatory integration may pose challenges in resource-limited settings, including increased workload and limited staffing; scalable solutions should be considered[6]. Identifying women with elevated symptoms at the mid-pregnancy peak creates a crucial opportunity for early intervention. This could include targeted psychoeducation, cognitive-behavioral therapy tailored to pregnancy-specific stressors, and bolstering social support networks before the arrival of the newborn[7]. Such a proactive model aims to build psychological resilience during pregnancy, effectively “immunizing” the mother to mitigate the severity or even the onset of PPD.

Navigating limitations and charting the future

While impactful, the study’s limitations, some of which the authors acknowledge, carefully frame its conclusions and, more importantly, chart an essential course for future research. Three key areas demand further exploration: The retrospective design and the etiological black box: As a retrospective study using hospital records, it can map associations but cannot prospectively investigate causes. The data lacks depth on the specific psychosocial stressors, lived experiences, and patient-perceived reasons for distress that drive the observed emotional curves. Future research must employ prospective, longitudinal designs that include qualitative or mixed-method components to ask why these fluctuations occur[8].

The need for unified, etiologically rich assessment. The use of different screening tools (generalized anxiety disorder-7/PHQ-9 prenatally, EPDS postpartum), while practical, introduces measurement discontinuity. Specifically, the overlap of somatic items in PHQ-9 may inflate prenatal scores compared with postpartum EPDS, potentially influencing the observed time-lagged predictive effects[9]. More critically, these scales are designed to measure symptom severity, not etiology. There is a pressing need to develop and validate new, unified assessment tools for the entire perinatal continuum. These tools should capture not only the intensity of symptoms but also their perceived triggers, coping resources, and biological correlates[10]. Future studies of biological correlates should adopt a longitudinal design paralleling cross-lagged symptom trajectories (e.g., inflammatory cytokines or cortisol dynamics) to better capture temporal dynamics[11].

Enhancing generalizability and understanding global patterns. The single-center, urban, and relatively well-educated sample from Suzhou, China, limits generalizability. The experience of perinatal mental health is deeply mediated by socioeconomic, cultural, and healthcare-system factors[12]. The recurring pattern of mild-to-moderate symptom fluctuation is a signal that must be investigated across diverse settings. Multinational, culturally adapted studies are essential to determine if these temporal dynamics are universal or context-dependent, ensuring that prevention strategies are effective globally.

Conclusion: Toward an integrated and investigative continuum of care

Gao and Lu’s work[2] underscores that the perinatal period is a psychologically continuous spectrum. Their analysis provides a data-driven blueprint for clinical practice: Effective PPD prevention must begin during pregnancy with integrated, stage-specific monitoring. However, the study also highlights that our current research paradigms have reached a frontier. The next imperative is to move from observing predictive pathways to understanding their mechanistic underpinnings. By investing in prospective studies, inventing richer assessment tools, and pursuing global research collaboration, we can transform predictive models into truly preventative, personalized interventions. The ultimate goal remains clear: To vigilantly care for the maternal mind throughout the entire perinatal journey, thereby building a foundation for lasting health for mothers, infants, and families worldwide.